MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 0.82 and traded as high as GBX 1.15. MaxCyte shares last traded at GBX 1.09, with a volume of 2,168,560 shares changing hands.
MaxCyte Stock Up 6.9%
The company has a market cap of £1.16 million, a PE ratio of -0.03 and a beta of 1.13. The stock’s 50 day moving average price is GBX 0.82 and its 200-day moving average price is GBX 1.14. The company has a debt-to-equity ratio of 9.70, a quick ratio of 14.38 and a current ratio of 12.39.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
Featured Stories
- Five stocks we like better than MaxCyte
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
